DividendChannel.com

ABT Forecast

Recent ABT Price   ABT Forecast Price
$105.27 ABT forecast: higher
+21.17%
$127.56
 As of 2024-04-19
Recent ABT Analyst Ratings Breakdown
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 13 12 12 12
Buy ratings: 2 2 2 2
Hold ratings: 4 4 4 4
Sell ratings: 0 0 0 0
Strong sell ratings: 0 0 0 0
Average rating: 1.53 1.56 1.56 1.56
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

For the Abbott Laboratories forecast (traded under symbol ABT) for one year forward price target at the top of this page, we have presented the average ABT forecast for forward target price across the 16 analysts covering ABT, as reported in data provided by Zacks Investment Research via Quandl.com.

Meanwhile, note that the median ABT forecast price target (median being the middle where half of analysts had a higher ABT forecast and half had a lower ABT forecast, which is a different metric than the average or mean) was $128.0 as of 2024-04-19, while the highest ABT forecast in the analyst group was $141.0, and the lowest ABT forecast in the analyst group was $107.0, with a standard deviation of $8.406. Get the latest Zacks research report on ABT — FREE

Slideshow Dividend Growth Stocks: 25 Aristocrats
Slideshow 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did

Name: 
Abbott Laboratories
Stock buyback: 
ABT buyback
Website: 
www.abbottinvestor.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding ABT: 
119 (see which ones)
Total Market Value Held by ETFs: 
$23,590,209,442.8
Total Market Capitalization: 
$183,849,000,000
% of Market Cap. Held by ETFs: 
12.83%
ABT Next Earnings Date »
ABT Next Dividend Date »
(Projection based upon history)
ABT Dividend Growth Rate »
Quotes delayed 20 minutes

Buy (3.47 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ABT Forecast | www.DividendChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.